GENG YUHE/FOR CHINA DAILY BEIJING -- China has highlighted its commitment to encouraging the long-term operation and development of foreign-funded pharmaceutical companies in the country.

Third quarter 2024 results were reviewed by management during a conference call with the financial community on Friday October 25, 2024. The presentation was followed by a Q&A session. We’re proud to ...

Get detailed information on Diphenhydramine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

The FDA proposed discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed, because it 'is not effective' in treating cold and flu symptoms.

Here, we take a more detailed look at the top 10 companies by market cap we reviewed in the table above.

The minister said five major pharma companies—Dr Reddy's Laboratories, Aurobindo Pharma, Hetero, Laurus Labs, and MSN Pharmaceuticals—have already committed to significant investments in the ...

Meanwhile, the defendant's counsel argued that the trademark "Relief" is generic in the pharmaceutical field, claiming the plaintiff cannot monopolize common words or shapes used in medicines. They ...

You can help confirm this entry by contributing facts, media, and other evidence of notability and mutation. The exact origins of the rumored "Benadryl challenge" are unknown. However, on July 14th, ...

Two homegrown healthcare companies, backed by private equity firms General Atlantic and TPG, have received approval from capital markets regulator Securities and Exchange Board of India (SEBI) to go ...

With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history.

This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company wins its appeal, or up to two years if it loses the case entirely. On ...